Home › NDC Lookup › RxCUI directory › RxCUI 200220

Tolcapone 100 MG Oral Tablet — RxCUI 200220

RxNorm drug concept · Semantic clinical drug
RxCUI 200220 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI200220
Official nameTolcapone 100 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped3
Package NDCs mapped3
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Tolcapone: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Levodopa is the main treatment for Parkinson's disease, but over time it can wear off between doses, causing your symptoms to return before your next pill. Tolcapone blocks an enzy...
  • Why do I need tolcapone if I'm already taking levodopa and carbidopa?
  • This is a real and serious risk that you should take seriously. Rare cases of fatal liver failure have been reported, mostly in the first six months of treatment. Your doctor will...
  • I heard tolcapone can cause liver problems. How serious is that, and what should I watch for?
📖 Read our full Tolcapone guide →

🕸️ Concept Web — How Tolcapone 100 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Tolcapone 100 MG Oral Tablet RxCUI 200220

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Tolcapone 72937
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Tasmar 153657
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Tolcapone Oral Tablet 374153
    • Tolcapone Oral Product 1162734
    • Tolcapone Pill 1162735
    • Tolcapone Oral Tablet [Tasmar] 368293
    • Tasmar Oral Product 1179059
    • Tasmar Pill 1179060
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Tolcapone 100 MG SCDC · 316837
  • Tolcapone Oral Tablet SCDF · 374153
  • Tolcapone Oral Product SCDG · 1162734
  • Tolcapone Pill SCDG · 1162735

Brand-Name Concepts

  • Tolcapone 100 MG Oral Tablet [Tasmar] SBD · 153655
  • Tolcapone 100 MG [Tasmar] SBDC · 565346
  • Tolcapone Oral Tablet [Tasmar] SBDF · 368293
  • Tasmar Oral Product SBDG · 1179059
  • Tasmar Pill SBDG · 1179060
  • Tasmar BN · 153657

📦 FDA Products & Package NDCs

3 products · 3 package NDCs
3 package NDCs map to RxCUI 200220 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00187-0938-01 90 TABLET, FILM COATED in 1 BOTTLE (0187-0938-01) Tasmar Bausch Health US LLC 2004-07-27
50742-0193-90 90 TABLET in 1 BOTTLE (50742-193-90) TOLCAPONE Ingenus Pharmaceuticals, LLC 2018-08-21
68682-0938-90 90 TABLET, FILM COATED in 1 BOTTLE (68682-938-90) Tolcapone Oceanside Pharmaceuticals 2004-07-27
Observed labelers: Bausch Health US LLC (1) · Ingenus Pharmaceuticals, LLC (1) · Oceanside Pharmaceuticals (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.